| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246098 | Journal of Vascular and Interventional Radiology | 2014 | 10 Pages |
Abstract
Serum miR-210 may represent a novel biomarker for predicting efficacy of transarterial chemoembolization and overall survival for patients with HCC.
Keywords
qRT-PCRmRECISTMicroRNA-210TTPBCLCHCCα-fetoproteinoverall survivalmiR-210stable diseaseprogressive diseaseAFPmodified Response Evaluation Criteria in Solid TumorsMicroRNAMiRNAquantitative real-time polymerase chain reactionPartial responsecomplete responseHepatocellular carcinomaBarcelona Clinic Liver Cancer
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Meixiao MS, Yong MS, Baoshan BS, Xu MS, Jianwen MS, Yan MS, Sirui MS, Ligong MD, PhD,